A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Dec, 15 2025
Feb, 16 2026
Apr, 16 2026
Mar, 22 2025
Jan, 29 2026